scholarly journals P2-195: Phase 2 trial of cisplatin (C), etoposide (E), and radiation (RT) followed by gemcitabine (G) vs G and docetaxel (D) in stage III A/B unresectable non-small-cell lung cancer (NSCLC)

2007 ◽  
Vol 2 (8) ◽  
pp. S648 ◽  
Author(s):  
Benjamin Movsas ◽  
Corey Langer ◽  
L.H. Wang ◽  
Robert Jotte ◽  
F Xu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Stage Iii ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Phase 2 Trial ◽  
Stage Iii A

Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial

2020 ◽  
Vol 21 (6) ◽  
pp. 786-795 ◽  
Author(s):  
Catherine A Shu ◽  
Justin F Gainor ◽  
Mark M Awad ◽  
Codruta Chiuzan ◽  
Claud M Grigg ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Phase 2 ◽  
Small Cell Lung ◽  
Open Label ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document